期刊文献+

低分子肝素与普通肝素治疗不稳定型心绞痛的疗效观察 被引量:3

Clinical observation of low molecular weight heparin and standard heparin in the treatment of unstable angina pectoris
下载PDF
导出
摘要 目的 观察低分子肝素(LMWH)与普通肝素(SH)治疗不稳定型心绞痛(UAP)的有效性和安全性。方法 符合入选条件的106例UAP患者随机分为3组。A组(38例)常规口服肠溶阿司匹林;B组(35例)及C组(33例)在口服肠溶阿司匹林基础上分别联用低分子肝素钙及普通肝素钠。比较3组临床疗效以及安全性。结果B组患者心绞痛症状明显缓解且出血并发症少。结论应用低分子肝素是治疗UAP安全、有效的方法且使用方便。
出处 《中国心血管杂志》 2004年第5期370-372,共3页 Chinese Journal of Cardiovascular Medicine
  • 相关文献

参考文献7

  • 1江一清.不稳定心绞痛的机理和防治新进展[J].中国急救医学,1995,15(4):48-55. 被引量:79
  • 2许俊堂.急性冠状动脉综合征的概念、分型[J].中国临床医生杂志,2002,30(9):2-3. 被引量:7
  • 3Ribeiro PA, Shah PM. Unstable angina: new insights into pathophysiologic characteristics, prognosis and management strategies [J] Curr Probl Cardiol, 1996,21 : 669 732.
  • 4Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin forunstable coronary artery disease.Efficacy and safety of subcutaneous enoxaparin in Non-Q-Wave coronary events study group [J]. N Engl J Meal,1997,337:447-452.
  • 5Goodman SG, Cohen M, Bigonzi F, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one- yearresults of the ESSENCE Study. Efficacy and safety of subcutaneous enoxaparin in Non-Q wave coronary events [J]. J Am Coil Cardiol. 2000,36 : 693-698.
  • 6Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) llB trial [J]. Circulation,1999,100:1593-1601.
  • 7Cohen M, Theroux P, Borzak S, et al. Randomized doubleblind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The antithrombotic combination using tirofiban and enoxaparin[J]. Am Heart J, 2002,144:470-477.

二级参考文献5

共引文献83

同被引文献14

  • 1白清中,裴瑞泽,袁国胜,李文.尿激酶联合低分子肝素钙治疗进展性脑梗死32例疗效观察[J].实用神经疾病杂志,2004,7(5):27-28. 被引量:1
  • 2张天民,崔慧斐,王凤山,罗振,李华,王福清,杨立波,李素霞,沈渤江.高抗血栓活性的低分子肝素[J].中国医药工业杂志,1994,25(7):301-309. 被引量:38
  • 3童春容,张石革,陆慰萱,张永红,左杏果.血液系统合理用药专家圆桌会纪要[J].中国医院用药评价与分析,2005,5(3):131-133. 被引量:4
  • 4邱贵兴,戴尅戎,杨庆铭,裴福兴,陈百成,曾炳芳,陈安民,王坤正,王继芳,余楠生,周乙雄,孙天胜,刘强,胡永成.预防骨科大手术后深静脉血栓形成的专家建议——深静脉血栓形成预防座谈会纪要[J].中华骨科杂志,2005,25(10):636-640. 被引量:477
  • 5陈灏珠.内科学[M].北京:人民卫生出版社,1996.576-584.
  • 6汪洋主编.现代心血管危重症监护与治疗实用全书.中卷.第1版.吉林:吉林科技出版社,2004:566
  • 7Cohen M, Theroux P, Borzak S, et al .Randomized double blind safety study of enoxaparin versus unfraetionated heparin in patients with non- ST- segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE Ⅱ study.The antithrombotic combination using tirofiban and enoxaparin[J].Am Heart, 2002,144(6): 470.
  • 8Granger CB, Galliff RM, Tope EL, et al .Thrombolytic therapy for acute myocardial infarction[J]. Drug, 1992,44: 293.
  • 9Charles J, Richard A, Luann S, et al. Enoxaparin prevent progression of stages Ⅰ and Ⅱ osteonecrosis of the hip [J]. Clinical Orthopaedics and Related Research,2005,435(6) : 164.
  • 10中华医学会心血管学分会,中华心血管病杂志编辑委员会.不稳定型心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28:409-412.

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部